Rheumatoid Arthritis clinical trials in Tuscaloosa, AL

1 recruiting rheumatoid arthritis studies with a site in Tuscaloosa, AL.

All trials in Tuscaloosa, AL · All Rheumatoid Arthritis trials

RecruitingPhase 2NCT06991114

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Sponsor: Artiva Biotherapeutics, Inc.

Tuscaloosa, AL · +30 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.